Murine ML-DS leukemia models and ML-DS patients show loss-of-function mutations in EZH2 and other PRC2 members, supporting the PRC2 role in transition from TAM to ML-DS (Labuhn et al., 2019). The gene discussed is EZH2; the disease is Dravet syndrome.